Literature DB >> 9558473

The luteinizing hormone receptor.

M L Dufau1.   

Abstract

The luteinizing hormone receptor (LHR) is a member of the subfamily of glycoprotein hormone receptors within the superfamily of G protein-coupled receptor (GPCR)/seven-transmembrane domain receptors. Over the past eight years, major advances have been made in determining the structure and function of the LHR and its gene. The hormone-binding domain has been localized to exons 1-7 in the extracellular (EC) domain/region of the receptor, which contains several leucine-rich repeats. High-affinity binding of LH and human chorionic gonadotrophin (hCG) causes secondary hormone or receptor contacts to be established with regions of the EC loop/transmembrane module that initiate signal transduction. Models of hormone-receptor interaction have been derived from the crystal structures of hCG and of the ribonuclease inhibitor, which also contains leucine-rich repeats. Such models provide a framework for the interpretation of mutational studies and for further experiments. The extracellular domain of the receptor has been overexpressed in vitro, which will facilitate crystallographic resolution of the structure of the receptor-binding site. The transmembrane domain/loop/cytoplasmic module transduces the signal for coupling to G proteins. Several constitutive, activating mutations that cause human disease have been found in helix VI and adjacent structures. These mutations have provided valuable information about mechanisms of signal transfer and G protein coupling. The structure of the LHR gene has been elucidated, and the regulation of its transcription is beginning to be understood. Valuable insights into receptor evolution have been derived from analysis of sequence homologies, the gene structure of glycoprotein hormone receptors and other members of the GPCR family, and the glycoprotein hormone receptor-like precursors identified in several invertebrate species.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558473     DOI: 10.1146/annurev.physiol.60.1.461

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  70 in total

1.  Cloning of partial putative gonadotropin hormone receptor sequence from fish.

Authors:  G Kumaresan; T Venugopal; A Vikas; T J Pandian; S Mathavan
Journal:  J Biosci       Date:  2000-03       Impact factor: 1.826

Review 2.  The normal human menstrual cycle.

Authors:  N Chabbert-Buffet; P Bouchard
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

3.  Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor.

Authors:  J Sun; J A Ember; T H Chao; Y Fukuoka; R D Ye; T E Hugli
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

4.  Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.

Authors:  Ying Zhang; Mingjuan Liao; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

5.  FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs.

Authors:  Dimitris Loutradis; Eleni Patsoula; Vassilis Minas; Giorgos A Koussidis; Aristeidis Antsaklis; Stylianos Michalas; Antonis Makrigiannakis
Journal:  J Assist Reprod Genet       Date:  2006-05-19       Impact factor: 3.412

6.  Trans-activation, cis-activation and signal selection of gonadotropin receptors.

Authors:  MyoungKun Jeoung; ChangWoo Lee; Inhae Ji; Tae H Ji
Journal:  Mol Cell Endocrinol       Date:  2006-10-19       Impact factor: 4.102

7.  Distinct mechanisms of cAMP induction by constitutively activating LH receptor and wild-type LH receptor activated by hCG.

Authors:  ChangWoo Lee; Inhae Ji; Tae H Ji
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

8.  Leutinizing hormone/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome.

Authors:  Wassim Y Almawi; Bayan Hubail; Dana Z Arekat; Suhaila M Al-Farsi; Shadha K Al-Kindi; Mona R Arekat; Naeema Mahmood; Samira Madan
Journal:  J Assist Reprod Genet       Date:  2015-02-04       Impact factor: 3.412

9.  Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB.

Authors:  Ying Zhang; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 10.  Endocrine disruptors and Leydig cell function.

Authors:  K Svechnikov; G Izzo; L Landreh; J Weisser; O Söder
Journal:  J Biomed Biotechnol       Date:  2010-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.